A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT01899729 · COMPLETED
Trial details
- NCT number
- NCT01899729
- Sponsor
- Idera Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-04-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.